PMID: 428695Apr 1, 1979Paper

Metformin in management of pregnant insulin-independent diabetics

Diabetologia
E J Coetzee, W P Jackson

Abstract

Sixty pregnant "maturity-onset" (insulin-independent), established and gestational, diabetics were treated with Metformin in the second and third trimester after dietary treatment had failed. The incidence of Metformin failure was 53.8% in the established diabetics and 28.6% in the "gestational" diabetics. The 27 Metformin failures were transferred to other therapy, leaving for further analysis 33 patients who received Metformin up till delivery. Two neonatal deaths occurred in this group (1 congenital abnormality and 1 preterm infant) giving a perinatal mortality of 61/1000. This compares with a perinatal mortality of 103/1000 in the Metformin failure group and 105/1000 in a group of insulin-dependent diabetics treated during the same period. Apart from a high incidence of neonatal jaundice requiring phototherapy the infant morbidity in the Metformin group was low. The mothers of 3 infants with congenital abnormalities had received Metformin only during the last trimester of their pregnancy.

References

Dec 1, 1977·American Journal of Obstetrics and Gynecology·S G GabbeE J Quilligan
Mar 25, 1978·British Medical Journal·N G Soler
Jul 1, 1970·The Journal of Pediatrics·L M DubowitzC Goldberg
Sep 27, 1952·British Medical Journal·W P U JACKSON
May 1, 1952·Annals of Eugenics·W F F KEMSLEY

❮ Previous
Next ❯

Citations

Jul 18, 2003·Current Diabetes Reports·Charles J GlueckPing Wang
Jul 18, 2003·Current Diabetes Reports·Carol J Homko, E Albert Reece
Dec 6, 2011·Current Diabetes Reports·Jerasimos BallasGladys A Ramos
Apr 6, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Yilmaz SahinErcan Aygen
Sep 15, 2004·Fertility and Sterility·UNKNOWN Practice Committee of the American Society for Reproductive Medicine
May 4, 2005·Fertility and Sterility·Eszter VankySven Magnus Carlsen
Jan 10, 2001·Endocrinology and Metabolism Clinics of North America·L Jovanovic
Jun 1, 1990·Baillière's Clinical Endocrinology and Metabolism·A DornhorstD G Johnston
Apr 29, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·N N ChanM D Feher
Sep 6, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·E HellmuthL Mølsted-Pedersen
Sep 6, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·T Dornan, S Hollis
Jun 25, 1998·The New England Journal of Medicine·J E NestlerR Pasquali
Oct 19, 2000·The New England Journal of Medicine·O LangerO Gonzales
May 9, 2008·The New England Journal of Medicine·Janet A RowanUNKNOWN MiG Trial Investigators
Oct 31, 2002·Human Reproduction·Charles J GlueckLuann Sieve-Smith
May 29, 2004·Obstetrical & Gynecological Survey·Nam D TranJerome Yankowitz
Oct 29, 2003·Obstetrical & Gynecological Survey·Alex C VidaeffSusan M Ramin
Jan 31, 2004·Obstetrical & Gynecological Survey·Elizabeth A McCarthyMichael Permezel
Jul 29, 2008·Current Opinion in Obstetrics & Gynecology·Stefano PalombaFulvio Zullo
Feb 28, 1987·British Medical Journal·N J Vaughan
Sep 1, 1994·Postgraduate Medical Journal·M D Littley
Jul 20, 2005·Treatments in Endocrinology·Carol J HomkoAlbert E Reece
Jul 12, 2014·Human Reproduction Update·Vanitha N SivalingamEmma J Crosbie
Mar 3, 2015·Indian Journal of Endocrinology and Metabolism·Awadhesh Kumar Singh, Ritu Singh
Mar 11, 2008·Journal of Women's Health·Willibald Zeck, H David McIntyre
Feb 28, 2001·Diabetes, Obesity & Metabolism·M J Iuorno, J E Nestler
Apr 10, 2003·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·O Langer
Nov 28, 2006·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Carol J Homko, E Albert Reece
Nov 24, 2011·Endocrinology and Metabolism Clinics of North America·Takako ArakiLeonid Poretsky
Jul 15, 2015·Taiwanese Journal of Obstetrics & Gynecology·Mawahib A S Al-Biate
Sep 14, 2010·Best Practice & Research. Clinical Endocrinology & Metabolism·David Simmons
Nov 11, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Kristiina TerttiKari Laine
Nov 26, 2008·Fertility and Sterility·UNKNOWN Practice Committee of American Society for Reproductive Medicine
Jun 19, 2007·Obstetrics and Gynecology Clinics of North America·Oded Langer
Mar 14, 2007·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Michal KovoMarek Glezerman
Nov 29, 2005·Endocrinology and Metabolism Clinics of North America·Oded Langer
Oct 13, 2005·Diabetes, Obesity & Metabolism·Mark O Goodarzi, Michael Bryer-Ash
Feb 24, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·R C E HughesM Zhang
Feb 20, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·C O EkpebeghN S Levitt
Aug 27, 2009·The Journal of Obstetrics and Gynaecology Research·Mosammat Rashida BegumAnowara Begum
Feb 24, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·G Hawthorne
Feb 24, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·R C E Hughes, J A Rowan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.